Side Effects and Contradictions to Pneumonia Vaccine
Contraindications to Receiving Pneumonia Vaccines Any patient who has had a known allergy to any of the pneumococcal vaccines or has had an allergic reaction to the diphtheria toxoid vaccination should not receive the PCV13 vaccination. Please make sure to speak with your healthcare provider about any known allergies to ensure that you are not allergic to any of the components used to create the vaccine. Patients who have an active infection should wait until they recover before obtaining the vaccination. Because of the limited research completed on the safety of the PCV13 vaccination during pregnancy, it should be avoided during this time if possible. The PPSV23 vaccine should not be given if the patient has experienced an allergic reaction to any of the components used to construct the vaccine, or has had an allergic reaction to any pneumococcal vaccine prior. Those patients who are actively sick should also refrain from receiving the vaccine until they recover if possible. Avoid this vaccination during pregnancy, as there has not been adequate research performed to determine its safety. Efficacy of the Pneumonia Vaccinations There have been numerous studies conducted that have indicated the efficacy of both these vaccines. The PCV13 (Prevnar 13) vaccine was found to protect approximately 75 out of every 100 adults age 65 or older against invasive pneumococcal disease; and approximately 45 out of every 100 adults age 65 or older against pneumococcal pneumonia serotypes present within this vaccine. The PPSV23 vaccine was found to protect between 50-85 out of every 100 healthy adults age 65 or older against pneumococcal invasive disease caused by the serotypes in the vaccine.